Cargando…
Increased serum levels of fractalkine and mobilisation of CD34(+)CD45(−) endothelial progenitor cells in systemic sclerosis
BACKGROUND: The disruption of endothelial homeostasis is a major determinant in the pathogenesis of systemic sclerosis (SSc) and is reflected by soluble and cellular markers of activation, injury and repair. We aimed to provide a combined assessment of endothelial markers to delineate specific profi...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359964/ https://www.ncbi.nlm.nih.gov/pubmed/28320472 http://dx.doi.org/10.1186/s13075-017-1271-7 |
_version_ | 1782516496537223168 |
---|---|
author | Benyamine, Audrey Magalon, Jérémy Cointe, Sylvie Lacroix, Romaric Arnaud, Laurent Bardin, Nathalie Rossi, Pascal Francès, Yves Bernard-Guervilly, Fanny Kaplanski, Gilles Harlé, Jean-Robert Weiller, Pierre-Jean Berbis, Philippe Braunstein, David Jouve, Elisabeth Lesavre, Nathalie Couranjou, Françoise Dignat-George, Françoise Sabatier, Florence Paul, Pascale Granel, Brigitte |
author_facet | Benyamine, Audrey Magalon, Jérémy Cointe, Sylvie Lacroix, Romaric Arnaud, Laurent Bardin, Nathalie Rossi, Pascal Francès, Yves Bernard-Guervilly, Fanny Kaplanski, Gilles Harlé, Jean-Robert Weiller, Pierre-Jean Berbis, Philippe Braunstein, David Jouve, Elisabeth Lesavre, Nathalie Couranjou, Françoise Dignat-George, Françoise Sabatier, Florence Paul, Pascale Granel, Brigitte |
author_sort | Benyamine, Audrey |
collection | PubMed |
description | BACKGROUND: The disruption of endothelial homeostasis is a major determinant in the pathogenesis of systemic sclerosis (SSc) and is reflected by soluble and cellular markers of activation, injury and repair. We aimed to provide a combined assessment of endothelial markers to delineate specific profiles associated with SSc disease and its severity. METHODS: We conducted an observational, single-centre study comprising 45 patients with SSc and 41 healthy control subjects. Flow cytometry was used to quantify circulating endothelial microparticles (EMPs) and CD34(+) progenitor cell subsets. Colony-forming unit-endothelial cells (CFU-ECs) were counted by culture assay. Circulating endothelial cells were enumerated using anti-CD146-based immunomagnetic separation. Blood levels of endothelin-1, vascular endothelial growth factor (VEGF) and soluble fractalkine (s-Fractalkine) were evaluated by enzyme-linked immunosorbent assay. Disease-associated markers were identified using univariate, correlation and multivariate analyses. RESULTS: Enhanced numbers of EMPs, CFU-ECs and non-haematopoietic CD34(+)CD45(−) endothelial progenitor cells (EPCs) were observed in patients with SSc. Patients with SSc also displayed higher serum levels of VEGF, endothelin-1 and s-Fractalkine. s-Fractalkine levels positively correlated with CD34(+)CD45(−) EPC numbers. EMPs, s-Fractalkine and endothelin-1 were independent factors associated with SSc. Patients with high CD34(+)CD45(−) EPC numbers had lower forced vital capacity values. Elevated s-Fractalkine levels were associated with disease severity, a higher frequency of pulmonary fibrosis and altered carbon monoxide diffusion. CONCLUSIONS: This study identifies the mobilisation of CD34(+)CD45(−) EPCs and high levels of s-Fractalkine as specific features of SSc-associated vascular activation and disease severity. This signature may provide novel insights linking endothelial inflammation and defective repair processes in the pathogenesis of SSc. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-017-1271-7) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5359964 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-53599642017-03-22 Increased serum levels of fractalkine and mobilisation of CD34(+)CD45(−) endothelial progenitor cells in systemic sclerosis Benyamine, Audrey Magalon, Jérémy Cointe, Sylvie Lacroix, Romaric Arnaud, Laurent Bardin, Nathalie Rossi, Pascal Francès, Yves Bernard-Guervilly, Fanny Kaplanski, Gilles Harlé, Jean-Robert Weiller, Pierre-Jean Berbis, Philippe Braunstein, David Jouve, Elisabeth Lesavre, Nathalie Couranjou, Françoise Dignat-George, Françoise Sabatier, Florence Paul, Pascale Granel, Brigitte Arthritis Res Ther Research Article BACKGROUND: The disruption of endothelial homeostasis is a major determinant in the pathogenesis of systemic sclerosis (SSc) and is reflected by soluble and cellular markers of activation, injury and repair. We aimed to provide a combined assessment of endothelial markers to delineate specific profiles associated with SSc disease and its severity. METHODS: We conducted an observational, single-centre study comprising 45 patients with SSc and 41 healthy control subjects. Flow cytometry was used to quantify circulating endothelial microparticles (EMPs) and CD34(+) progenitor cell subsets. Colony-forming unit-endothelial cells (CFU-ECs) were counted by culture assay. Circulating endothelial cells were enumerated using anti-CD146-based immunomagnetic separation. Blood levels of endothelin-1, vascular endothelial growth factor (VEGF) and soluble fractalkine (s-Fractalkine) were evaluated by enzyme-linked immunosorbent assay. Disease-associated markers were identified using univariate, correlation and multivariate analyses. RESULTS: Enhanced numbers of EMPs, CFU-ECs and non-haematopoietic CD34(+)CD45(−) endothelial progenitor cells (EPCs) were observed in patients with SSc. Patients with SSc also displayed higher serum levels of VEGF, endothelin-1 and s-Fractalkine. s-Fractalkine levels positively correlated with CD34(+)CD45(−) EPC numbers. EMPs, s-Fractalkine and endothelin-1 were independent factors associated with SSc. Patients with high CD34(+)CD45(−) EPC numbers had lower forced vital capacity values. Elevated s-Fractalkine levels were associated with disease severity, a higher frequency of pulmonary fibrosis and altered carbon monoxide diffusion. CONCLUSIONS: This study identifies the mobilisation of CD34(+)CD45(−) EPCs and high levels of s-Fractalkine as specific features of SSc-associated vascular activation and disease severity. This signature may provide novel insights linking endothelial inflammation and defective repair processes in the pathogenesis of SSc. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-017-1271-7) contains supplementary material, which is available to authorized users. BioMed Central 2017-03-20 2017 /pmc/articles/PMC5359964/ /pubmed/28320472 http://dx.doi.org/10.1186/s13075-017-1271-7 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Benyamine, Audrey Magalon, Jérémy Cointe, Sylvie Lacroix, Romaric Arnaud, Laurent Bardin, Nathalie Rossi, Pascal Francès, Yves Bernard-Guervilly, Fanny Kaplanski, Gilles Harlé, Jean-Robert Weiller, Pierre-Jean Berbis, Philippe Braunstein, David Jouve, Elisabeth Lesavre, Nathalie Couranjou, Françoise Dignat-George, Françoise Sabatier, Florence Paul, Pascale Granel, Brigitte Increased serum levels of fractalkine and mobilisation of CD34(+)CD45(−) endothelial progenitor cells in systemic sclerosis |
title | Increased serum levels of fractalkine and mobilisation of CD34(+)CD45(−) endothelial progenitor cells in systemic sclerosis |
title_full | Increased serum levels of fractalkine and mobilisation of CD34(+)CD45(−) endothelial progenitor cells in systemic sclerosis |
title_fullStr | Increased serum levels of fractalkine and mobilisation of CD34(+)CD45(−) endothelial progenitor cells in systemic sclerosis |
title_full_unstemmed | Increased serum levels of fractalkine and mobilisation of CD34(+)CD45(−) endothelial progenitor cells in systemic sclerosis |
title_short | Increased serum levels of fractalkine and mobilisation of CD34(+)CD45(−) endothelial progenitor cells in systemic sclerosis |
title_sort | increased serum levels of fractalkine and mobilisation of cd34(+)cd45(−) endothelial progenitor cells in systemic sclerosis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359964/ https://www.ncbi.nlm.nih.gov/pubmed/28320472 http://dx.doi.org/10.1186/s13075-017-1271-7 |
work_keys_str_mv | AT benyamineaudrey increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis AT magalonjeremy increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis AT cointesylvie increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis AT lacroixromaric increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis AT arnaudlaurent increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis AT bardinnathalie increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis AT rossipascal increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis AT francesyves increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis AT bernardguervillyfanny increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis AT kaplanskigilles increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis AT harlejeanrobert increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis AT weillerpierrejean increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis AT berbisphilippe increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis AT braunsteindavid increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis AT jouveelisabeth increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis AT lesavrenathalie increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis AT couranjoufrancoise increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis AT dignatgeorgefrancoise increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis AT sabatierflorence increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis AT paulpascale increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis AT granelbrigitte increasedserumlevelsoffractalkineandmobilisationofcd34cd45endothelialprogenitorcellsinsystemicsclerosis |